GlassScriptPhysician profile
Alan Benvenisty
NPI 1083765721
$1,628.94
in general payments reported to CMS, 2019-2025
11 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $249 · 2023: $469 · 2024: $434 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $712.48 | 2021-2025 | Collagenase Santyl, Regranex |
| Medtronic, INC. | $485.82 | 2021-2024 | Endurant Iis, In.Pact Av |
| Penumbra, INC. | $119.46 | 2022 | |
| Boston Scientific Corporation | $95.08 | 2025 | Ekosonic |
| Philips North America LLC | $60.90 | 2023 | |
| Abbott Laboratories | $51.81 | 2021 | |
| Humacyte Global, INC. | $32.50 | 2025 | Symvess |
| Janssen Pharmaceuticals, INC | $24.15 | 2024 | Xarelto |
| Advanced Oxygen Therapy INC. | $22.55 | 2024 | Topical Oxygen Chamber For Extremities |
| Kci USA, INC. | $22.09 | 2022 | |
| Cardiovascular Systems INC. | $2.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Benvenisty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.